Jj. Krupp et al., CALCIUM-DEPENDENT INACTIVATION OF RECOMBINANT N-METHYL-D-ASPARTATE RECEPTORS IS NR2 SUBUNIT-SPECIFIC, Molecular pharmacology, 50(6), 1996, pp. 1680-1688
Intracellular Ca2+ can reversibly reduce the activity of native N-meth
yl-D-aspartate (NMDA) receptors in hippocampal neurons, a phenomenon t
ermed Ca2+-dependent inactivation. We examined inactivation in heterom
eric NMDA receptors expressed in human embryonic kidney (HEK) 293 cell
s using whole-cell recording. NR1-1a/2A heteromers showed reversible i
nactivation that was very similar to native NMDA receptors in cultured
hippocampal neurons. Inactivation was dependent on the extracellular
Ca2+ concentration and the degree of intracellular Ca2+ buffering. In
2 mM extracellular Ca2+, inactivation resulted in a 46.1 +/- 12.6% red
uction in the whole-cell current during a 5-sec agonist application. I
nactivation of NR1-1a/2A heteromers was unaffected by calcineurin inhi
bitors, staurosporine, or phalloidin. NR1-1a/2D heteromers also showed
a similar degree of inactivation. In contrast, NR1-1a/2B and NR1-1a/2
C heteromers showed no significant inactivation. At saturating concent
rations of NMDA(I mM), NR1-1a/2A heteromers also showed Ca- and glycin
e-independent desensitization, as seen in native hippocampal neurons.
Ca2+- and glycine-independent desensitization Was less pronounced in N
R1-1a/2B heteromers and absent in NR1-1a/2C heteromers. Activation of
NR1-1a/2C heteromers triggered intracellular Ca2+ transients similar t
o NR1-1a/2A heteromers as verified by combined Ca2+ imaging and whole-
cell recording. Thus differences in Ca2+ permeability were not respons
ible for the lack of inactivation in NR1-1a/2C heteromers. Our results
show that inactivation of recombinant NMDA receptors requires either
the NR2A or NR2D subunit, whereas both inactivation and desensitizatio
n were absent in NR2C-containing receptors. The gating of inactivating
NMDA receptors is more likely to be influenced by ongoing NMDA recept
or activity and Ca2+ transients, perhaps consistent with the prominent
expression of NR2A in hippocampus and cerebral cortex.